G. Cropp
- Oncology top 5%
- Cancer Treatment and Pharmacology 23
- Colorectal Cancer Treatments and Studies 9
- Hematology top 5%
- Multiple Myeloma Research and Treatments 9
- Cell Biology top 10%
- Microtubule and mitosis dynamics 4
-
- Cancer therapeutics and mechanisms 7
- Ubiquitin and proteasome pathways 6
- Angiogenesis and VEGF in Cancer 6
-
- Cancer, Hypoxia, and Metabolism 10
- Co-authors
- Alison L. HannahAlison StopeckRobert G. JohnsonShanu ModiJennifer J. WhelerWeining MaMichael S. GordonClifford A. Hudis
- Cited by
- OncologyHematologyCell Biology
- Journals
- Journal of Clinical Oncology (19 papers)Blood (9 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesAustraliaEstonia
In The Last Decade
G. Cropp
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Oncology 518
- Hematology 193
- Cell Biology 159
- Molecular Biology 650
- Cancer Research 141
Countries citing papers authored by G. Cropp
This map shows the geographic impact of G. Cropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Cropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Cropp more than expected).
Fields of papers citing papers by G. Cropp
This network shows the impact of papers produced by G. Cropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Cropp. The network helps show where G. Cropp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Cropp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 9 | |
| 2 | 2011 | 15 | |
| 3 | 2011 | 3 | |
| 4 | 2010 | 85 | |
| 5 | 2008 | 5 | |
| 6 | Phase 1 clinical trials of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas | 2007 | 1 |
| 7 | 2007 | 24 | |
| 8 | 2007 | 2 | |
| 9 | 2007 | 8 | |
| 10 | 2007 | 3 | |
| 11 | 2007 | 266 | |
| 12 | 2006 | 17 | |
| 13 | 2006 | 10 | |
| 14 | 2006 | 26 | |
| 15 | 2005 | 4 | |
| 16 | 2005 | 27 | |
| 17 | 2005 | 7 | |
| 18 | 2004 | 25 | |
| 19 | Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. | 2002 | 121 |
| 20 | 1999 | 55 |
About G. Cropp
G. Cropp is a scholar working on Oncology, Hematology and Cancer Research, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (23 papers), Cancer, Hypoxia, and Metabolism (10 papers), Multiple Myeloma Research and Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer therapeutics and mechanisms (7 papers), Ubiquitin and proteasome pathways (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Oncology (518 citations), Hematology (193 citations) and Cell Biology (159 citations). G. Cropp has collaborated with scholars based in United States, Australia and Estonia. Frequent co-authors include Alison L. Hannah, Alison Stopeck, Robert G. Johnson, Shanu Modi, Jennifer J. Wheler, Weining Ma, Michael S. Gordon, Clifford A. Hudis, David S. Mendelson and Neal Rosen. Their work appears in journals such as Journal of Clinical Oncology, Blood, Investigational New Drugs, Cancer Chemotherapy and Pharmacology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.